EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseKohortenstudie

Effect of Gonadotropin‐Releasing Hormone Agonist Pre‐Treatment on Outcomes of Fresh and Frozen Embryo Transfers in Women With Adenomyosis: A Retrospective Cohort Study With Literature Review

Xin Li, Yixin Li, Hexiang Peng, Mengying Wang, Yuqi Liu, Tao Wu, Qing Xue

BJOG: An International Journal of Obstetrics & Gynaecology · 2025-04 · 132 (S2) · 62-74

DOI: 10.1111/1471-0528.18026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 17.12.2024. Verfasst von Xin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Embryo Transfer, Gonadotropin-Releasing Hormone, Adenomyosis, Infertility, Female. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National High Level Hospital Clinical Research Funding (Interdisciplinary Clinical Research Project of Peking University First Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the effect of gonadotropin‐releasing hormone agonist (GnRHa) pre‐treatment on the clinical outcomes of fresh and frozen embryo transfers (ETs and FETs, respectively) in infertile patients with adenomyosis.

Design

Retrospective cohort study with literature review.

Setting

Peking University First Hospital. Population We analysed 413 cycles of 369 women with adenomyosis who underwent ETs or FETs.

Methods

We performed logistic regression analysis and meta‐analysis to assess the association of GnRHa pre‐treatment with the clinical outcomes of ETs and FETs. Main Outcome Measures The live birth rate (LBR) was compared between patients with and without GnRHa pre‐treatment.

Results

The LBR was higher in the GnRHa pre‐treatment group than in the non‐GnRHa pre‐treatment group in ETs (41.27% vs. 24.32%, p = 0.034) and FETs (40.36% vs. 20.75%, p = 0.008). The odds of achieving a live birth of women with GnRHa pre‐treatment were 2.65 times higher than that of those without (95% CI: 1.19–5.92, p = 0.017) after adjusting for confounders in ETs. Similarly, the adjusted odds ratio (OR) was 2.43 (95% CI: 1.10–5.40, p = 0.029) in FETs. For the meta‐analysis, eight studies met the inclusion criteria; however, only six reported the adjusted ORs. Combination of these six adjusted ORs with our results revealed that the GnRHa pre‐treatment group had higher LBRs than the non‐GnRHa pre‐treatment group (ET: OR 1.71, 95% CI: 1.30–2.26, FET: OR 2.61, 95% CI: 1.52–4.49).

Conclusions

In women with adenomyosis, GnRHa pre‐treatment may be beneficial for LBRs following both ETs and FETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryo TransferGonadotropin-Releasing HormoneAdenomyosisInfertility, FemaleFertility Agents, FemaleHumansFemaleRetrospective StudiesPregnancyAdultPregnancy RateLive BirthTreatment OutcomeCryopreservationFertilization in Vitro

Stichwörter der Autor:innen

adenomyosisembryo transfergonadotropin‐releasing hormone agonistlive birth rate

Substanzen

Gonadotropin-Releasing HormoneFertility Agents, Female

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, People's Republic of China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
  • Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
  • Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Förderung

  • National Key Research and Development Program of China
  • National High Level Hospital Clinical Research Funding (Interdisciplinary Clinical Research Project of Peking University First Hospital

Zitieren

APA

Li, X., Li, Y., Peng, H., Wang, M., Liu, Y., Wu, T., & Xue, Q. (2025). Effect of Gonadotropin‐Releasing Hormone Agonist Pre‐Treatment on Outcomes of Fresh and Frozen Embryo Transfers in Women With Adenomyosis: A Retrospective Cohort Study With Literature Review. BJOG: An International Journal of Obstetrics & Gynaecology, 132(S2), 62-74. https://doi.org/10.1111/1471-0528.18026

Vancouver

Li X, Li Y, Peng H, Wang M, Liu Y, Wu T, et al. Effect of Gonadotropin‐Releasing Hormone Agonist Pre‐Treatment on Outcomes of Fresh and Frozen Embryo Transfers in Women With Adenomyosis: A Retrospective Cohort Study With Literature Review. BJOG: An International Journal of Obstetrics & Gynaecology. 2025;132(S2):62-74. doi:10.1111/1471-0528.18026

BibTeX
@article{Li2025,
  author = {Li, Xin and Li, Yixin and Peng, Hexiang and Wang, Mengying and Liu, Yuqi and Wu, Tao and Xue, Qing},
  title = {Effect of Gonadotropin‐Releasing Hormone Agonist Pre‐Treatment on Outcomes of Fresh and Frozen Embryo Transfers in Women With Adenomyosis: A Retrospective Cohort Study With Literature Review},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2025},
  volume = {132},
  number = {S2},
  pages = {62--74},
  doi = {10.1111/1471-0528.18026}
}
Kostenlos starten →